Evercore ISI Group analyst Liisa Bayko downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to In-Line and announces $14 price target.
Oxford Industries Q3 Adj. EPS $1.46 Beats $1.22 Estimate, Sales $313.03M Beat $303.37M Estimate
Oxford Industries (NYSE:OXM) reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $1.22 by 19.67 percent. This is a 22.69 percent increase over earnings of $1.19 per share from the
